Evidence map›Paper›PMID 39345556›Full record

ArticlebioRxiv : the preprint server for biology2024

Increased Inflammation as well as Decreased Endoplasmic Reticulum Stress and Translation Differentiate Pancreatic Islets of Pre-symptomatic Stage 1 Type 1 Diabetes and Non-diabetic Cases.

Adam C Swensen, Paul D Piehowski, Jing Chen, X'avia Y Chan, Shane S Kelly, Vladislav A Petyuk, Ronald J Moore, Lith Nasif, Elizabeth A Butterworth, Mark A Atkinson and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Adam C SwensenIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
Paul D PiehowskiIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.ORCID 0000-0001-5108-2227
Jing ChenDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
X'avia Y ChanIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
Shane S KellyIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
Vladislav A PetyukIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
Ronald J MooreIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
Lith NasifDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
Elizabeth A ButterworthDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.ORCID 0000-0001-7365-9832
Mark A AtkinsonDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.ORCID 0000-0001-8489-4782
Rohit N KulkarniSection of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA.
Martha Campbell-ThompsonDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.ORCID 0000-0001-6878-1235
Clayton E MathewsDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.ORCID 0000-0002-8817-6355
Wei-Jun QianIntegrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.ORCID 0000-0002-5393-2827

Funding

Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
Organ Specific ProjectU54DK127823 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI MATHEWS, CLAYTON E · 2020 to 2023
$5.1M
Pathways and Regulators Driving Progressive Islet Cell Dysfunction in Type 1 DiabetesR01DK122160 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI ROHIT N. KULKARNI, CLAYTON E MATHEWS · 2019 to 2026
$3.7M
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 DiabetesR01DK135081 · NIDDK · UNIVERSITY OF FLORIDA · PI CLAYTON E MATHEWS, DAVID A OSTROV · 2023 to 2026
$2.8M
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and ApoptosisUC4DK104167 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI KULKARNI, ROHIT N., MATHEWS, CLAYTON E · 2014 to 2016
$2.7M
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetesR01DK123329 · NIDDK · UNIVERSITY OF FLORIDA · PI CAMPBELL-THOMPSON, MARTHA, HALLER, MICHAEL JAMES · 2020 to 2024
$2.6M
Defining Islet Heterogeneity Using Single Islet TranscriptomicsUC4DK104155 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CAMPBELL-THOMPSON, MARTHA, GERLING, IVAN C · 2014 to 2014
$1.6M
Leica Laser Microdissection Microscope for a Shared ResourceS10OD016350 · OD · UNIVERSITY OF FLORIDA · PI CAMPBELL-THOMPSON, MARTHA · 2013 to 2013
$252k
NIAID NIH HHS P01 AI042288NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK122160NIDDK NIH HHS R01 DK123329NIDDK NIH HHS R01 DK135081NIDDK NIH HHS U54 DK127823NIDDK NIH HHS UC4 DK104155NIDDK NIH HHS UC4 DK104167NIH HHS S10 OD016350
6 · The paper itself

Abstract

Aims/hypothesis: Progression to type 1 diabetes (T1D) is associated with genetic factors, the presence of autoantibodies, and a decline in β cell insulin secretion in response to glucose. Very little is known regarding the molecular changes that occur in human insulin-secreting β-cells prior to the onset of T1D. Herein, we applied an unbiased proteomics approach to identify changes in proteins and potential mechanisms of islet dysfunction in islet autoantibody-positive organ donors with pre-symptomatic stage 1 T1D (HbA1c ≤ 6). We aimed to identify pathways in islets that are indicative of β-cell dysfunction. Methods: Multiple islet sections were collected through laser microdissection of frozen pancreatic tissues of organ donors positive for islet autoantibodies (AAb+, n=5), compared to age/sex-matched nondiabetic controls (ND, n=5) obtained from the Network for Pancreatic Organ donors with Diabetes (nPOD). Islet sections were subjected to mass spectrometry-based proteomics and analyzed with label-free quantification followed by pathway and functional annotations. Results: Analyses resulted in ~4,500 proteins identified with low false discovery rate (FDR) <1%, with 2,165 proteins reliably quantified in every islet sample. We observed large inter-donor variations that presented a challenge for statistical analysis of proteome changes between donor groups. We therefore focused on the three multiple AAb+ cases (mAAb+) with high genetic risk and their three matched controls for a final statistical analysis. Approximately 10% of the proteins (n=202) were significantly different between mAAb+ cases versus ND. The significant alterations clustered around major functions for upregulation in the immune response and glycolysis, and downregulation in endoplasmic reticulum (ER) stress response as well as protein translation and synthesis. The observed proteome changes were further supported by several independent published datasets, including proteomics dataset from Conclusion/interpretation: In-situ human islet proteome alterations at the stage 1 of AAb+ T1D centered around several major functional categories, including an expected increase in immune response genes (elevated antigen presentation / HLA), with decreases in protein synthesis and ER stress response, as well as compensatory metabolic response. The dataset serves as a proteomics resource for future studies on β cell changes during T1D progression and pathogenesis.

Indexed as

autoantibody-positivehuman isletsislet proteomelaser microdissectionmass spectrometrynPODpre-T1Dproteomicsβ-cells

Identifiers

PMID39345556
PMCPMC11429719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.